Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Outset Medical (OM) Gross Margin (2019 - 2025)

Outset Medical (OM) has disclosed Gross Margin for 7 consecutive years, with 42.36% as the latest value for Q4 2025.

  • On a quarterly basis, Gross Margin rose 589.0% to 42.36% in Q4 2025 year-over-year; TTM through Dec 2025 was 39.13%, a 521.0% increase, with the full-year FY2025 number at 39.13%, up 521.0% from a year prior.
  • Gross Margin was 42.36% for Q4 2025 at Outset Medical, up from 39.38% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 42.36% in Q4 2025 to a low of 1.26% in Q1 2021.
  • A 5-year average of 23.59% and a median of 22.47% in 2023 define the central range for Gross Margin.
  • Peak YoY movement for Gross Margin: skyrocketed 5083bps in 2021, then skyrocketed 205bps in 2025.
  • Outset Medical's Gross Margin stood at 11.8% in 2021, then surged by 40bps to 16.47% in 2022, then skyrocketed by 53bps to 25.28% in 2023, then surged by 44bps to 36.47% in 2024, then grew by 16bps to 42.36% in 2025.
  • Per Business Quant, the three most recent readings for OM's Gross Margin are 42.36% (Q4 2025), 39.38% (Q3 2025), and 37.77% (Q2 2025).